A Phase 3 trial evaluating the efficacy, duration of effect, and safety of DaxibotulinumtoxinA for Injection in the treatment of cervical dystonia

Authors
Category Primary study
ConferenceMovement Disorder
Year 2021
This article has no abstract
Epistemonikos ID: da971bb636574939966b4a1ba2104df1e81c1993
First added on: Apr 30, 2026